en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2023
vol. 98
 
Share:
Send email
Share:
abstract:
Review paper

Proton pump inhibitors – their possible influence on the development of small intestine bacterial overgrowth in children

Zuzanna Wasielewska
1
,
Aneta Krogulska
1
,
Anna Szaflarska-Popławska
2

  1. Department of Pediatrics, Allergology and Gastroenterology, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland
  2. Department of Pediatrics Endoscopy and Gastrointestinal Function Testing, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland
Pediatr Pol 2023; 98 (2): 154-160
DOI: https://doi.org/10.5114/polp.2023.128720
Online publish date: 2023/06/19
View full text Get citation
 
PlumX metrics:
Proton pump inhibitors (PPIs) are safe drugs that have been commonly used for many years by both general practitioners and specialists. They are widely used in the paediatric population, mainly in the treatment of gastroesophageal reflux disease, but also for oesophagitis, gastritis and/or duodenitis. Proton pump inhibitors use increases the pH of the stomach, which disrupts the physiological defensive barrier and may lead to the development of an abnormal microbiome in the further parts of the digestive tract, resulting in small intestinal bacterial overgrowth (SIBO) and symptoms such as diarrhoea, production of gas, nonspecific abdominal pain, flatulence, lack of growth or weight loss, protein or energy malnutrition, and vitamin A, D, K and B12 deficiency. The study analyses the influence of combining PPIs with probiotics or prokinetics on the chance of SIBO developing in children. There are currently no diagnostic standards or therapeutic guidelines for children diagnosed with SIBO.
keywords:

children, proton pump inhibitors, small intestinal bacterial overgrowth, gut microbiome, small intestine bacterial overgrowth